AU2018102141A4 - Method for preparing Baricitinib - Google Patents

Method for preparing Baricitinib Download PDF

Info

Publication number
AU2018102141A4
AU2018102141A4 AU2018102141A AU2018102141A AU2018102141A4 AU 2018102141 A4 AU2018102141 A4 AU 2018102141A4 AU 2018102141 A AU2018102141 A AU 2018102141A AU 2018102141 A AU2018102141 A AU 2018102141A AU 2018102141 A4 AU2018102141 A4 AU 2018102141A4
Authority
AU
Australia
Prior art keywords
compound
mixture
reacted
added
baricitinib
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018102141A
Other languages
English (en)
Inventor
Shuang HUANG
Weisi LI
Jingyu TANG
Siqing WU
Qiang Xu
Jian Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd
Original Assignee
JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd filed Critical JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd
Application granted granted Critical
Publication of AU2018102141A4 publication Critical patent/AU2018102141A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2018102141A 2017-12-13 2018-07-03 Method for preparing Baricitinib Active AU2018102141A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201711334329.1A CN108129482A (zh) 2017-12-13 2017-12-13 一种巴瑞替尼的制备方法
CN201711334329.1 2017-12-13
CN201810667443.4A CN108586465B (zh) 2017-12-13 2018-06-25 一种巴瑞替尼的制备方法
CN201810667443.4 2018-06-25

Publications (1)

Publication Number Publication Date
AU2018102141A4 true AU2018102141A4 (en) 2019-10-03

Family

ID=62389618

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018366342A Pending AU2018366342A1 (en) 2017-12-13 2018-07-03 Method for preparing Baricitinib
AU2018102141A Active AU2018102141A4 (en) 2017-12-13 2018-07-03 Method for preparing Baricitinib

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2018366342A Pending AU2018366342A1 (en) 2017-12-13 2018-07-03 Method for preparing Baricitinib

Country Status (3)

Country Link
CN (2) CN108129482A (zh)
AU (2) AU2018366342A1 (zh)
WO (1) WO2019114258A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053690A1 (en) * 2019-09-17 2021-03-25 Natco Pharma Limited An improved process for the preparation of baricitinib

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129482A (zh) * 2017-12-13 2018-06-08 江苏中邦制药有限公司 一种巴瑞替尼的制备方法
CN111362853A (zh) * 2020-04-27 2020-07-03 安徽大学 一种3-氧杂氮杂环丁烷-1-羧酸叔丁酯的制备方法
CN112898306B (zh) * 2021-02-02 2022-04-08 山东四环药业股份有限公司 一种巴瑞替尼的制备方法
CN115124537A (zh) * 2022-07-13 2022-09-30 山东大学 一种jak抑制剂巴瑞替尼的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3035395A1 (de) * 1980-09-19 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von pyrazol
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
ES2602577T3 (es) * 2008-03-11 2017-02-21 Incyte Holdings Corporation Derivados de azetidina y ciclobutano como inhibidores de JAK
WO2016088094A1 (en) * 2014-12-05 2016-06-09 Sun Pharmaceutical Industries Limited Process for the preparation of baricitinib and an intermediate thereof
WO2016125080A2 (en) * 2015-02-02 2016-08-11 Sun Pharmaceutical Industries Limited Process for the preparation of baricitinib and an intermediate thereof
AR104918A1 (es) * 2015-06-19 2017-08-23 Lilly Co Eli Procesos e intermediarios para la preparación de {1-(etilsulfonil)-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]azetidin-3-il}acetonitrilo
CN105294699B (zh) * 2015-12-04 2019-06-11 上海勋和医药科技有限公司 巴瑞替尼的制备方法
CN105541891B (zh) * 2016-02-04 2017-11-28 东南大学 巴瑞替尼的中间体及其制备方法及由该中间体制备巴瑞替尼的方法
CN106496195B (zh) * 2016-10-18 2019-03-08 杭州科巢生物科技有限公司 巴瑞替尼及其中间体的合成方法
CN106946917B (zh) * 2017-03-20 2019-06-11 杭州科巢生物科技有限公司 一种jak抑制剂巴瑞替尼及其中间体的新合成方法
CN107176955B (zh) * 2017-03-24 2019-04-09 南京优科制药有限公司 一种巴瑞替尼的制备方法
CN107739328B (zh) * 2017-11-22 2020-03-20 海化生命(厦门)科技有限公司 用于合成巴瑞替尼的关键中间体1的制备方法
CN108129482A (zh) * 2017-12-13 2018-06-08 江苏中邦制药有限公司 一种巴瑞替尼的制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053690A1 (en) * 2019-09-17 2021-03-25 Natco Pharma Limited An improved process for the preparation of baricitinib

Also Published As

Publication number Publication date
AU2018366342A1 (en) 2019-07-04
CN108586465B (zh) 2020-06-02
CN108586465A (zh) 2018-09-28
CN108129482A (zh) 2018-06-08
WO2019114258A1 (zh) 2019-06-20

Similar Documents

Publication Publication Date Title
AU2018102141A4 (en) Method for preparing Baricitinib
CN1060768C (zh) 吡唑和吡唑并嘧啶
BRPI0714573A2 (pt) processo para preparar um composto, e, composto
WO2016026380A1 (zh) 艾德拉尼的制备方法
CN111770917B (zh) 两种化合物的制备方法
KR20170131508A (ko) 레디파스비르 및 이의 유도체의 제조방법 및 레디파스비르를 제조하기 위한 중간체 화합물
CN107915738A (zh) 用于合成巴瑞替尼的关键中间体2的制备方法
WO2009143684A1 (zh) 培美曲塞二钠及其中间体4-(4-甲酯基苯基)丁醛的制备方法
CN112851646A (zh) 特戈拉赞的制备方法
JP6454707B2 (ja) ｔｒａｎｓ−８−クロロ−５−メチル−１−［４−（ピリジン−２−イルオキシ）−シクロヘキシル］−５，６−ジヒドロ−４Ｈ−２，３，５，１０ｂ−テトラアザ−ベンゾ［ｅ］アズレン及びその結晶形態の合成
CN1688588A (zh) 制备噻吩并吡咯衍生物的方法和中间体
US20170369437A1 (en) Process for Preparing Alpha-Carboxamide Pyrrolidine Derivatives
CN108358799B (zh) 一种普瑞巴林的制备方法
CN108912030B (zh) 一种艾瑞昔布的合成方法
CN109384767B (zh) 一种吡啶并嘧啶类衍生物的制备方法及其中间体
CN110016023B (zh) 一种帕博西尼的简便制备方法
JP2002520313A (ja) ケトロラクの製造に有用な化合物の合成
WO1997043265A1 (fr) Procedes de preparation d'un compose pyrimidine
CN101573034A (zh) 合成(+)及(-)-1-(3,4-二氯苯基)-3-氮杂双环[3.1.0]己烷的方法
CN107188909B (zh) 一种合成吲哚取代或二茂铁取代氮杂芳烃的方法
JP6235560B2 (ja) （３，４−ジクロロ−フェニル）−（（ｓ）−３−プロピル−ピロリジン−３−イル）−メタノン塩酸塩及び製造方法
CN105153039A (zh) 一种瑞舒伐他汀钙中间体杂质的制备方法
IL281283B2 (en) Improved method for the production of 3-[(1S)-1-imidazolo[1,2-A]pyridine-6-ylethyl]-5-(1-methylpyrazol-1-YL]triazolo[4,5-B]pyrazine and polymeric forms His
CN112457231A (zh) 一种拉罗替尼（Larotrectinib）中间体的消旋化方法
Dhara et al. An iron-catalyzed domino reaction of donor–acceptor cyclopropanes: a diastereoselective approach towards diversely functionalized pyrrolo-quinazolines

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)